Expert Opinion on Investigational Drugs
Last updated ISSN 1354-3784
Expert Opinion on Investigational Drugs is published by Taylor & Francis in medicine. It is a subscription journal. Its article processing charge is not published.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close Expert Opinion on Investigational Drugs is — and show you journals like it.
What it publishes
Recent work in Expert Opinion on Investigational Drugs concentrates on these topics, taken from its published record rather than from its own description:
- Monoclonal and Polyclonal Antibodies Research
- Diabetes Treatment and Management
- Asthma and respiratory diseases
- Lipoproteins and Cardiovascular Health
- HIV/AIDS drug development and treatment
- HER2/EGFR in Cancer Research
- Neurotransmitter Receptor Influence on Behavior
- Immunotherapy and Immune Responses
- Cancer Treatment and Pharmacology
- Angiogenesis and VEGF in Cancer
Key facts
| Publisher | Taylor & Francis |
|---|---|
| ISSN | 1354-3784, 1744-7658 |
| Subject area | Medicine |
| Access | Subscription |
| Article processing charge | Not published |
| Indexed in | Web of Science — Science Citation Index Expanded · Scopus |
| Articles published | 5,097 |
| Publishing since | 1968 |
| Journal website | informahealthcare.com/loi/eid |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like Expert Opinion on Investigational Drugs
Other established journals in medicine, if this one is not the right home for your paper: